NCT03819426

Brief Summary

After an initial phone screen process, approximately 50 participants will be enrolled and evaluated/screened in person after consenting to achieve 30 eligible participants with a principal diagnosis of GAD, panic disorder, or social anxiety disorder and high anxiety sensitivity (Anxiety Sensitivity Index score =20). Participants will be given a choice of either high intensity interval training (HIIT) or walking interventions, which will be completed over the course of 8 weeks. The goal of the study is to 1) obtain pilot data comparing the efficacy of HIIT vs. walking for effects on psychiatric, functioning and immune outcomes, 2) to identify adherence levels given the choice of exercise intensity, and 3) to identify proportion of individuals opting for each intervention. Results from this pilot study will be used to inform future grant applications including a K award.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

December 11, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 28, 2019

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 29, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 29, 2020

Completed
Last Updated

September 28, 2020

Status Verified

September 1, 2020

Enrollment Period

1.6 years

First QC Date

October 29, 2018

Last Update Submit

September 25, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Efficacy of HIIT measured by Quality of Life Enjoyment & Satisfaction Questionnaire (Q-LES-Q-SF)

    Scoring involves summing only the first 14 items to yield a raw total score. The last two items are not included in the total score but are stand alone items. The raw score ranges from 14 to 70.

    Week 1

  • Efficacy of HIIT measured by Quality of Life Enjoyment & Satisfaction Questionnaire (Q-LES-Q-SF)

    Scoring involves summing only the first 14 items to yield a raw total score. The last two items are not included in the total score but are stand alone items. The raw score ranges from 14 to 70.

    Week 10

Study Arms (2)

High Intensity Interval Training

EXPERIMENTAL

Participants will be shown the appropriate techniques and intensity (high intensity; i.e., 70-90% of maximum heart rate (220-age) with a verified online youtube video. Participants will be provided with this video and other options that can be followed to complete 15 minute HIIT interventions at home. Interventionist will observe participant engaging in HIIT for 15 minutes. HIIT intervention (for 15 minutes) will also be observed during Session 4 and 8.

Behavioral: High Intensity Intervention

Walking

EXPERIMENTAL

This intervention will be demonstrated during Session 1. Participants will be shown the appropriate walking intensity (low intensity; i.e., approximately 50% of maximum heart rate (220-age) or lower) by interventionist. Interventionist will observe participant engaging in walking at appropriate intensity level for 15 minutes. Walking intervention (for 15 minutes) will also be observed during Session 4 and 8.

Behavioral: Low Intensity Exercise Intervention

Interventions

Those in the walking intervention will be instructed to take walks below a brisk pace (low intensity) to improve mood

Walking

Instructed in high intensity interval training techniques and will be provided videos to follow for implementation of intervention at home that will include short bursts of high energy

High Intensity Interval Training

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Anxiety Sensitivity Index score of ≥20 (i.e., high anxiety sensitivity)
  • Primary psychiatric diagnosis of generalized anxiety disorder (GAD), social anxiety disorder, or panic disorder
  • Currently sedentary (≤60 minutes of moderate intensity exercise per week for the past 3 months)
  • Able and willing to provide informed consent

You may not qualify if:

  • Lifetime history of Bipolar I or II or any psychotic disorder
  • Meets criteria for bulimia or anorexia in the past 6 months
  • Meets criteria for substance use disorder in the past 3 months
  • High current suicide risk as indicated by a score of ≥4 on the C-SSRS
  • Risk for exercise according to Physical Activity Readiness Questionnaire with excluded medical conditions including heart conditions, lung disease, bone/joint problems, or seizures
  • Women who are currently pregnant or plan to become pregnant during the duration of the study
  • Participation in concurrent evidence-based therapy (e.g., cognitive behavioral therapy) targeting anxiety or depression (supportive therapy and couples therapy are allowed)
  • Participants on psychiatric medication must be on a stable dose for ≥8 weeks prior to participation
  • Current substance abuse or positive urine toxic screen (recreational use of marijuana is permitted based on clinical assessment on the MINI that it does not meet criteria for cannabis use disorder)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NYU Langone

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

Generalized Anxiety DisorderPanic Disorder

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Study Officials

  • Kristin Szuhany, PhD

    NYU Langone

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 29, 2018

First Posted

January 28, 2019

Study Start

December 11, 2018

Primary Completion

July 29, 2020

Study Completion

July 29, 2020

Last Updated

September 28, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will share

Any requests for data will be considered on a case by case basis given the pilot nature of this project. As this is a pilot study, there will not be sufficient data for systematic sharing. Means of participant data will be shared on clinicaltrials.gov.

Time Frame
On a case by case basis, given the pilot nature of this project.
Access Criteria
Requests should be directed to Kristin.szuhany@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.

Locations